DK32286A - Fremgangsmaade til fremstilling af 1-substituerede aryl-1,4-dihydro-4-oxanaphthyridinderivater, mellemprodukter til brug ved fremgangsmaaden og fremgangsmaade til fremstilling af disse - Google Patents

Fremgangsmaade til fremstilling af 1-substituerede aryl-1,4-dihydro-4-oxanaphthyridinderivater, mellemprodukter til brug ved fremgangsmaaden og fremgangsmaade til fremstilling af disse Download PDF

Info

Publication number
DK32286A
DK32286A DK32286A DK32286A DK32286A DK 32286 A DK32286 A DK 32286A DK 32286 A DK32286 A DK 32286A DK 32286 A DK32286 A DK 32286A DK 32286 A DK32286 A DK 32286A
Authority
DK
Denmark
Prior art keywords
procedure
preparation
oxanaphthyridine
dihydro
intermediates
Prior art date
Application number
DK32286A
Other languages
English (en)
Other versions
DK32286D0 (da
DK169570B1 (da
Inventor
Yozo Todo
Tetsuo Yamafuji
Katsuyuki Nagumo
Isao Kitayama
Hideyoshi Nagaki
Mikako Miyajima
Yoshinori Konishi
Hirokazu Narita
Shuntaro Takano
Isamu Saikawa
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP60009191A external-priority patent/JPH0629247B2/ja
Priority claimed from JP60028397A external-priority patent/JPH0629246B2/ja
Priority claimed from JP60043644A external-priority patent/JPH0665670B2/ja
Priority claimed from JP60069061A external-priority patent/JPH0665671B2/ja
Priority claimed from JP60097065A external-priority patent/JPH0662619B2/ja
Priority claimed from JP60129323A external-priority patent/JPH0665672B2/ja
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of DK32286D0 publication Critical patent/DK32286D0/da
Publication of DK32286A publication Critical patent/DK32286A/da
Application granted granted Critical
Publication of DK169570B1 publication Critical patent/DK169570B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
DK032286A 1985-01-23 1986-01-22 Fremgangsmåde til fremstilling af 1-substituerede aryl-1,4-dihydro-4-oxonaphthyridinderivater DK169570B1 (da)

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
JP919185 1985-01-23
JP60009191A JPH0629247B2 (ja) 1985-01-23 1985-01-23 ５−フルオロニコチン酸誘導体およびその塩
JP60028397A JPH0629246B2 (ja) 1985-02-18 1985-02-18 ２−（５−フルオロニコチノイル）酢酸誘導体およびその塩
JP2839785 1985-02-18
JP4364485 1985-03-07
JP60043644A JPH0665670B2 (ja) 1985-03-07 1985-03-07 １，４−ジヒドロ−４−オキソナフチリジン誘導体およびその塩
JP6906185 1985-04-03
JP60069061A JPH0665671B2 (ja) 1985-04-03 1985-04-03 １−置換アリ−ル−１，４−ジヒドロ−４−オキソナフチリジン誘導体またはその塩の新規製造法
JP9706585 1985-05-08
JP60097065A JPH0662619B2 (ja) 1985-05-08 1985-05-08 １，４−ジヒドロ−４−オキソナフチリジン誘導体またはその塩の新規製造法
JP60129323A JPH0665672B2 (ja) 1985-06-14 1985-06-14 １，４−ジヒドロ−４−オキソナフチリジン誘導体またはその塩の新規製造法
JP12932385 1985-06-14

Publications (3)

Publication Number Publication Date
DK32286D0 DK32286D0 (da) 1986-01-22
DK32286A true DK32286A (da) 1986-07-24
DK169570B1 DK169570B1 (da) 1994-12-05

Family

ID=27548185

Family Applications (3)

Application Number Title Priority Date Filing Date
DK032286A DK169570B1 (da) 1985-01-23 1986-01-22 Fremgangsmåde til fremstilling af 1-substituerede aryl-1,4-dihydro-4-oxonaphthyridinderivater
DK285290A DK170532B1 (da) 1985-01-23 1990-11-30 5-Fluornicotinsyrederivat eller salt heraf eller reaktivt derivat i carboxylgruppen heraf
DK285190A DK170857B1 (da) 1985-01-23 1990-11-30 2-(5-Fluornicotinoyl)eddikesyrederivat og fremgangsmåde til fremstilling heraf

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK285290A DK170532B1 (da) 1985-01-23 1990-11-30 5-Fluornicotinsyrederivat eller salt heraf eller reaktivt derivat i carboxylgruppen heraf
DK285190A DK170857B1 (da) 1985-01-23 1990-11-30 2-(5-Fluornicotinoyl)eddikesyrederivat og fremgangsmåde til fremstilling heraf

Country Status (20)

Country Link
US (1) US4704459A (da)
KR (1) KR880001078B1 (da)
AT (1) AT392789B (da)
BE (1) BE904086A (da)
CA (2) CA1340706C (da)
CH (2) CH667456A5 (da)
DE (2) DE3637679C1 (da)
DK (3) DK169570B1 (da)
FI (2) FI83313C (da)
FR (1) FR2576305B1 (da)
GB (2) GB2170804B (da)
IL (1) IL77688A (da)
IT (1) IT1190193B (da)
LU (1) LU86264A1 (da)
NL (1) NL192986C (da)
NO (1) NO163227C (da)
NZ (1) NZ214901A (da)
PH (2) PH22956A (da)
PT (1) PT81889B (da)
SE (3) SE462164B (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3525108A1 (de) * 1985-06-07 1986-12-11 Bayer Ag, 5090 Leverkusen Antibakteriell wirksame chinoloncarbonsaeureester
US4916229A (en) * 1987-07-28 1990-04-10 Warner-Lambert Company Pyridine carboxylic acid derivates
IE62600B1 (en) * 1987-08-04 1995-02-22 Abbott Lab Naphtyridine antianaerobic compounds
DE3729852A1 (de) * 1987-09-05 1989-03-23 Basf Ag Verfahren zur herstellung von 1-alkylimidazol-5-carbonsaeuren sowie deren estern, amiden und nitrilen
US4920120A (en) * 1988-01-25 1990-04-24 Warner-Lambert Company Antibacterial agents
US5585491A (en) * 1988-01-25 1996-12-17 Otsuka Pharmaceutical Co., Ltd. Antibacterial agents
US5262417A (en) * 1988-12-06 1993-11-16 The Upjohn Company Antibacterial quinolone compounds
DE3934082A1 (de) * 1989-10-12 1991-04-18 Bayer Ag Chinoloncarbonsaeurederivate, verfahren zu ihrer herstellung sowie ihre verwendung als antivirale mittel
EP0449445A3 (en) * 1990-03-27 1993-08-25 Pfizer Inc. Preparation of beta-ketoesters useful in preparing quinolone antibiotics
EP0571400A1 (en) * 1991-01-14 1993-12-01 Hanmi Pharmaceutical Co.,Ltd. Novel quinolone compounds and processes for preparation thereof
US5532239A (en) * 1993-08-02 1996-07-02 Assistance Publique - Hopitaux De Paris Therapeutic application of fluoroquinolone derivatives
JP2758722B2 (ja) * 1993-08-13 1998-05-28 ドング ホワ ファーマシューチカル インダストリアル カンパニー，リミテッド 新規キノロンカルボン酸誘導体
US5858408A (en) * 1994-07-20 1999-01-12 Toyama Chemical Co., Ltd. Sustained-release oral ointment
AU7940598A (en) 1997-06-26 1999-01-19 Dong Wha Pharmaceutical Industrial Co., Ltd. Quinolone carboxylic acid derivatives
CA2353557A1 (en) 1998-12-04 2000-06-08 Influx, Inc. Inhibitors of multidrug transporters
MY123528A (en) * 1999-09-16 2006-05-31 Mitsubihsi Tanabe Pharma Corp Aromatic nitrogen-containing 6-membered cyclic compounds.
US7273868B2 (en) * 2000-04-28 2007-09-25 Tanabe Seiyaku Co., Ltd. Pyrazine derivatives
US20080027037A1 (en) * 2000-04-28 2008-01-31 Tanabe Seiyaku Co., Ltd. Cyclic compounds
AU4114201A (en) * 2000-04-28 2001-11-12 Tanabe Seiyaku Co Cyclic compounds
AU2002233706C1 (en) * 2001-02-26 2005-12-22 Tanabe Seiyaku Co., Ltd. Pyridopyrimidine or naphthyridine derivative
US6957105B2 (en) * 2002-03-26 2005-10-18 Cardiac Pacemakers, Inc. Method and apparatus for detecting oscillations in cardiac rhythm with electrogram signals
DE10312346A1 (de) * 2003-03-20 2004-09-30 Bayer Healthcare Ag Kontrolliertes Freisetzungssystem
DE10351448A1 (de) 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
US7517994B2 (en) * 2003-11-19 2009-04-14 Array Biopharma Inc. Heterocyclic inhibitors of MEK and methods of use thereof
US7732616B2 (en) * 2003-11-19 2010-06-08 Array Biopharma Inc. Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof
WO2005051301A2 (en) * 2003-11-19 2005-06-09 Array Biopharma Inc. Heterocyclic inhibitors of mek and methods of use thereof
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
CN101626767A (zh) * 2005-05-18 2010-01-13 阵列生物制药公司 Mek的杂环抑制剂及其使用方法
US20070197548A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone compositions
US7973022B2 (en) * 2006-02-17 2011-07-05 Idexx Laboratories, Inc. Fluoroquinolone carboxylic acid salt compositions
US20070196398A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone fatty acid salt compositions
DE102006010642A1 (de) * 2006-03-08 2007-09-27 Bayer Healthcare Aktiengesellschaft Arzneimittelformulierungen, enthaltend Fluorchinolone
DE102006010643A1 (de) 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Arzneimittel enthaltend Fluorchinolone
WO2007123939A2 (en) * 2006-04-19 2007-11-01 Laboratoires Serono S.A. Novel arylamino n-heteraryls as mek inhibitors
DE102007026550A1 (de) 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudate mit verbesserter Geschmacksmaskierung
DE102007055341A1 (de) * 2007-11-19 2009-05-20 Bayer Animal Health Gmbh Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren
RU2010137639A (ru) * 2008-02-11 2012-03-20 Астразенека Аб (Se) Способ получения производных пиридона 226
CN103200930A (zh) 2010-10-12 2013-07-10 拜耳知识产权有限责任公司 非淀粉基软咀嚼品
JP6393274B2 (ja) 2012-12-19 2018-09-19 バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ａｎｉｍａｌ Ｈｅａｌｔｈ Ｇｍｂｈ 改良された許容性および良好な保存安定性を有する錠剤
MD4291C1 (ro) * 2013-12-27 2015-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Preparat medicamentos pentru tratamentul otitelor
WO2021046305A1 (en) * 2019-09-06 2021-03-11 Bayer Healthcare Llc Palatable granular veterinary compositions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3149104A (en) * 1961-01-03 1964-09-15 Sterling Drug Inc 4-hydroxy-7-styryl-1, 8-naphthyridine-3-carboxylic acids and esters
GB1147336A (en) * 1965-06-14 1969-04-02 Lilly Industries Ltd Quinoline-3-carboxylic acid derivatives
US3753993A (en) * 1971-05-17 1973-08-21 Sterling Drug Inc 1,4-dihydro-4-oxo-7-pyridyl-3-quinoline-carboxylic acid derivatives
DE2125310A1 (en) * 1971-05-21 1972-11-30 Sterling Drug Inc , New York, NY (V St A) 1-alkyl-1,4-dihydro-4-oxo-1,8-naphtyridine 3-carboxylic acids antibac
GB1451912A (en) * 1972-08-14 1976-10-06 Dainippon Pharmaceutical Co 2-1-piperazino-5-oxopyrido-2,3-d-pyridine-6-carboxylic acids their preparation and pharmaceutical compositions thereof
US4017622A (en) * 1972-12-18 1977-04-12 Dainippon Pharmaceutical Co., Ltd. Piperazine derivatives
DE2808070A1 (de) * 1978-02-24 1979-08-30 Bayer Ag Verfahren zur herstellung von 4-pyridon-3-carbonsaeuren und/oder deren derivaten
AR223983A1 (es) * 1978-08-25 1981-10-15 Dainippon Pharmaceutical Co Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico
US4350817A (en) * 1980-02-28 1982-09-21 American Home Products Corporation 4-Cl, Br or I-3-Carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphthyridine derivatives
DE3028520A1 (de) * 1980-07-28 1982-02-25 Dynamit Nobel Ag, 5210 Troisdorf Verfahren zur herstellung von chinolinen, naphtyridinen und anderen stickstoff-bi-heterocyclen
DE3142854A1 (de) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-piperazino-chinolin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
JPS60228479A (ja) * 1984-04-26 1985-11-13 Toyama Chem Co Ltd １，４−ジヒドロ−４−オキソナフチリジン誘導体およびその塩

Also Published As

Publication number Publication date
DE3601517C2 (da) 1989-11-16
SE8902264L (sv) 1989-06-21
AT392789B (de) 1991-06-10
NO163227C (no) 1990-04-25
NL192986B (nl) 1998-03-02
SE8600274D0 (sv) 1986-01-22
SE8902265L (sv) 1989-06-21
FI860250A0 (fi) 1986-01-20
FI893075A (fi) 1989-06-22
CH671957A5 (da) 1989-10-13
DK32286D0 (da) 1986-01-22
NO860226L (no) 1986-07-24
IT8647562A0 (it) 1986-01-22
FI83313C (fi) 1991-06-25
KR880001078B1 (ko) 1988-06-22
GB2170804A (en) 1986-08-13
FR2576305A1 (fr) 1986-07-25
NO163227B (no) 1990-01-15
SE462164B (sv) 1990-05-14
NZ214901A (en) 1989-01-27
GB2204040A (en) 1988-11-02
NL8600138A (nl) 1986-08-18
PH22956A (en) 1989-02-03
CA1340706C (en) 1999-08-17
SE8902264D0 (sv) 1989-06-21
CH667456A5 (de) 1988-10-14
NL192986C (nl) 1998-07-03
IL77688A (en) 1991-01-31
FI87647B (fi) 1992-10-30
GB8601045D0 (en) 1986-02-19
GB2204040B (en) 1989-09-20
KR860005817A (ko) 1986-08-13
DK169570B1 (da) 1994-12-05
PT81889B (pt) 1988-05-27
FI83313B (fi) 1991-03-15
SE469984B (sv) 1993-10-18
DK285190D0 (da) 1990-11-30
PT81889A (en) 1986-02-01
FR2576305B1 (fr) 1991-04-19
ATA7286A (de) 1990-11-15
DK285290A (da) 1990-11-30
GB8811645D0 (en) 1988-06-22
US4704459A (en) 1987-11-03
CA1340783C (en) 1999-10-12
FI893075A0 (fi) 1989-06-22
GB2170804B (en) 1989-09-20
DK170532B1 (da) 1995-10-16
PH23202A (en) 1989-06-06
SE8600274L (sv) 1986-09-10
DK285190A (da) 1990-11-30
FI860250A (fi) 1986-07-24
SE8902265D0 (sv) 1989-06-21
DK285290D0 (da) 1990-11-30
FI87647C (fi) 1993-02-10
IT1190193B (it) 1988-02-16
LU86264A1 (fr) 1986-08-04
SE469983B (sv) 1993-10-18
DE3637679C1 (de) 1992-08-27
BE904086A (fr) 1986-07-22
DK170857B1 (da) 1996-02-12
DE3601517A1 (de) 1986-08-21

Similar Documents

Publication Publication Date Title
DK32286A (da) Fremgangsmaade til fremstilling af 1-substituerede aryl-1,4-dihydro-4-oxanaphthyridinderivater, mellemprodukter til brug ved fremgangsmaaden og fremgangsmaade til fremstilling af disse
DK425583A (da) Fremgangsmaade til fremstilling af 4'-demethyl-epipodophyllotoxin-beta-d-ethylidenglycocid og acylderivater deraf samt mellemprodukt til brug ved fremgangsmaaden
DK158586A (da) Holder til medicinsk brug og fastgjort ved hjaelp af vakuum
NO984084D0 (no) 4-Amino-pyrimidin-derivater, medikamenter inneholdende disse forbindelser, deres anvendelse og fremgangsmÕte ved fremstilling derav
DK166058C (da) Fremgangsmaade ved transmission af data, og modtager til brug ved fremgangsmaaden
DK335686D0 (da) Fremgangsmaade til fremstilling af 1-carba-3-cephem-4-carboxylsyrer ogderivater deraf samt mellemprodukter til brug ved fremgangsmaaden
DK514688A (da) Heterocykliske peptidylforbindelser, fremgangsmaade til fremstilling deraf samt anvendelse af disse
DK525085A (da) Fremgangsmaade til splejsning af roerformede hylstre og tape til brug ved fremgangsmaaden
DK435588D0 (da) Aralkylaminoalkoxyphenylderivater, fremgangsmaade til deres fremstilling og midler indeholdende disse
DK407383D0 (da) Diaminopyrimidiner, fremgangsmader til deres fremstilling, deres anvendelse og mellemprodukter anvendelige ved forbindelsernes fremstilling
DK228386D0 (da) Praeparat og fremgangsmaade til paavisning af urease og anordning til brug ved fremgangsmaaden
DK145485D0 (da) Fremgangsmaade til fremstilling af pyrrolidon-derivater og mellemprodukter til brug ved udoevelse af fremgangsmaaden
DK54787A (da) Fremgangsmaade til fremstilling af l-alfa-hydroxyvitamin d forbindelser og mellemprodukter til brug herved
DK579786D0 (da) Imidazopyridazinalkensyreamider, deres fremstilling og anvendelse samt mellemprodukter til brug ved fremstillingen
DK399485D0 (da) Fremgangsmaade ved undersoegelse med ultralyd og ultralyd-leder til brug ved udoevelse af fremgangsmaaden
DK164785C (da) 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner, deres fremstilling og deres anvendelse til fremstilling af antipedressive midler
DK239385A (da) Krystallinske metallophosphoaluminater samt fremgangsmaade til fremstilling og anvendelse af disse
DK2489A (da) Anvendelse af benzimidazolderivater, benzimidazolderivater og fremstillingen heraf samt ved fremgangsmaaden anvendelige mellemprodukter og fremstillingen heraf
DK93385A (da) 3-amino-1-(4,5,6,7-tetrahydro-benzothiazolyl)-2-pyrazoliner, fremgangsmaade til fremstilling af disse forbindelser og farmaceutiske praeparater indeholdende disse forbindelser
DK492785D0 (da) Fremgangsmaade til fremstilling af milbemycinderivater og forbindelser til anvendelse ved fremgangsmaaden
DK232184A (da) Fremgangsmaade til fremstilling af 4-halogenmethylthiazoler og mellemprodukt til brug ved fremgangsmaaden
DK436887D0 (da) Fremgangsmaade til fremstilling af triazol-tetrahydrofuran-derivater og mellemprodukter til anvendelse herved
DK47387A (da) Acylerede sulfonylquanidiner, fremstilling og anvendelse deraf, samt mellemprodukter til deres fremstilling og fremstilling af disse
DK271087A (da) (2,5-dihydro-2-oxo-5-phenyl-3-furanyl)aminer, fremgangsmaade til deres fremstilling og deres anvendelse ved fremstillingen af ace-inhibitorer
DK148389D0 (da) Fremgangsmaade til fremstilling af polydichlorphosphazenpraeparater og de ved fremgangsmaaden fremstillede praeparater

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired